• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 - 2025
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Therapy area
o Market segments
o Rheumatoid arthritis - Market size and forecast 2020-2025
o Multiple sclerosis - Market size and forecast 2020-2025
o Psoriasis - Market size and forecast 2020-2025
o Inflammatory bowel disease - Market size and forecast 2020-2025
o Others - Market size and forecast 2020-2025
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2020-2025
o Europe - Market size and forecast 2020-2025
o Asia - Market size and forecast 2020-2025
o ROW - Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o AbbVie Inc.
o Amgen Inc.
o Bristol-Myers Squibb Co.
o F. Hoffmann-La Roche Ltd.
o GlaxoSmithKline Plc
o Johnson and Johnson Inc.
o Novartis AG
o Pfizer Inc.
o Sanofi SA
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2020 - 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 - 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2020
• 21: Other1 - Market share 2020-2025 (%)
• 22: Comparison by Other1
• 23: Rheumatoid arthritis - Market size and forecast 2020-2025 ($ million)
• 24: Rheumatoid arthritis - Year-over-year growth 2020-2025 (%)
• 25: Multiple sclerosis - Market size and forecast 2020-2025 ($ million)
• 26: Multiple sclerosis - Year-over-year growth 2020-2025 (%)
• 27: Psoriasis - Market size and forecast 2020-2025 ($ million)
• 28: Psoriasis - Year-over-year growth 2020-2025 (%)
• 29: Inflammatory bowel disease - Market size and forecast 2020-2025 ($ million)
• 30: Inflammatory bowel disease - Year-over-year growth 2020-2025 (%)
• 31: Others - Market size and forecast 2020-2025 ($ million)
• 32: Others - Year-over-year growth 2020-2025 (%)
• 33: Market opportunity by Other1
• 34: Customer landscape
• 35: Market share By Geographical Landscape 2020-2025 (%)
• 36: Geographic comparison
• 37: North America - Market size and forecast 2020-2025 ($ million)
• 38: North America - Year-over-year growth 2020-2025 (%)
• 39: Europe - Market size and forecast 2020-2025 ($ million)
• 40: Europe - Year-over-year growth 2020-2025 (%)
• 41: Asia - Market size and forecast 2020-2025 ($ million)
• 42: Asia - Year-over-year growth 2020-2025 (%)
• 43: ROW - Market size and forecast 2020-2025 ($ million)
• 44: ROW - Year-over-year growth 2020-2025 (%)
• 45: Key leading countries
• 46: Market opportunity By Geographical Landscape ($ million)
• 47: Impact of drivers and challenges
• 48: Vendor landscape
• 49: Landscape disruption
• 50: Industry risks
• 51: Vendors covered
• 52: Market positioning of vendors
• 53: Abbott Laboratories - Overview
• 54: Abbott Laboratories - Business segments
• 55: Abbott Laboratories - Key offerings
• 56: Abbott Laboratories - Key customers
• 57: Abbott Laboratories - Segment focus
• 58: AbbVie Inc. - Overview
• 59: AbbVie Inc. - Product and service
• 60: AbbVie Inc. - Key offerings
• 61: AbbVie Inc. - Key customers
• 62: AbbVie Inc. - Segment focus
• 63: Amgen Inc. - Overview
• 64: Amgen Inc. - Business segments
• 65: Amgen Inc. - Key offerings
• 66: Amgen Inc. - Key customers
• 67: Amgen Inc. - Segment focus
• 68: Bristol-Myers Squibb Co. - Overview
• 69: Bristol-Myers Squibb Co. - Product and service
• 70: Bristol-Myers Squibb Co. - Key offerings
• 71: Bristol-Myers Squibb Co. - Key customers
• 72: Bristol-Myers Squibb Co. - Segment focus
• 73: F. Hoffmann-La Roche Ltd. - Overview
• 74: F. Hoffmann-La Roche Ltd. - Business segments
• 75: F. Hoffmann-La Roche Ltd. - Key offerings
• 76: F. Hoffmann-La Roche Ltd. - Key customers
• 77: F. Hoffmann-La Roche Ltd. - Segment focus
• 78: GlaxoSmithKline Plc - Overview
• 79: GlaxoSmithKline Plc - Business segments
• 80: GlaxoSmithKline Plc - Key offerings
• 81: GlaxoSmithKline Plc - Key customers
• 82: GlaxoSmithKline Plc - Segment focus
• 83: Johnson and Johnson Inc. - Overview
• 84: Johnson and Johnson Inc. - Business segments
• 85: Johnson and Johnson Inc. - Key offerings
• 86: Johnson and Johnson Inc. - Key customers
• 87: Johnson and Johnson Inc. - Segment focus
• 88: Novartis AG - Overview
• 89: Novartis AG - Business segments
• 90: Novartis AG - Key offerings
• 91: Novartis AG - Key customers
• 92: Novartis AG - Segment focus
• 93: Pfizer Inc. - Overview
• 94: Pfizer Inc. - Business segments
• 95: Pfizer Inc. - Key offerings
• 96: Pfizer Inc. - Key customers
• 97: Pfizer Inc. - Segment focus
• 98: Sanofi SA - Overview
• 99: Sanofi SA - Business segments
• 100: Sanofi SA - Key offerings
• 101: Sanofi SA - Key customers
• 102: Sanofi SA - Segment focus
• 103: Currency conversion rates for US$
• 104: Research Methodology
• 105: Validation techniques employed for market sizing
• 106: Information sources
• 107: List of abbreviations

Companies Mentioned
. Abbott Laboratories
. AbbVie Inc.
. Amgen Inc.
. Bristol-Myers Squibb Co.
. F. Hoffmann-La Roche Ltd.
. GlaxoSmithKline Plc
. Johnson and Johnson Inc.
. Novartis AG
. Pfizer Inc.
. Sanofi SA